| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000272699.1 |
Tipifarnib |
Breast invasive carcinoma |
0.03890559 |
Resistant |
| ENSG00000272699.1 |
Tipifarnib |
Brain lower grade glioma |
0.04599191 |
Resistant |
| ENSG00000272699.1 |
Tipifarnib |
Lung squamous cell carcinoma |
0.034874034 |
Resistant |
| ENSG00000272699.1 |
Tipifarnib |
Skin cutaneous melanoma |
0.039123513 |
Resistant |
